325 related articles for article (PubMed ID: 38561595)
1. DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy.
Wang MJ; Xia Y; Gao QL
Curr Med Sci; 2024 Apr; 44(2):261-272. PubMed ID: 38561595
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences.
Song X; Ma F; Herrup K
J Neurosci; 2019 Aug; 39(32):6378-6394. PubMed ID: 31189575
[TBL] [Abstract][Full Text] [Related]
3. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy.
Jiang M; Jia K; Wang L; Li W; Chen B; Liu Y; Wang H; Zhao S; He Y; Zhou C
Acta Pharm Sin B; 2021 Oct; 11(10):2983-2994. PubMed ID: 34729299
[TBL] [Abstract][Full Text] [Related]
4. SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Liu XD; Zhang YT; McGrail DJ; Zhang X; Lam T; Hoang A; Hasanov E; Manyam G; Peterson CB; Zhu H; Kumar SV; Akbani R; Pilie PG; Tannir NM; Peng G; Jonasch E
Clin Cancer Res; 2023 Oct; 29(19):4002-4015. PubMed ID: 37527013
[TBL] [Abstract][Full Text] [Related]
5. Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer.
Gulliver C; Hoffmann R; Baillie GS
Int J Biochem Cell Biol; 2022 Jun; 147():106230. PubMed ID: 35609768
[TBL] [Abstract][Full Text] [Related]
6. WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.
Wu X; Kang X; Zhang X; Xie W; Su Y; Liu X; Guo L; Guo E; Li F; Hu D; Qin X; Fu Y; Peng W; Jia J; Wang C
Cancer Sci; 2021 Nov; 112(11):4444-4456. PubMed ID: 34382294
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cGAS-STING signalling in cancer: Approach for combination therapy.
Vasiyani H; Wadhwa B; Singh R
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188896. PubMed ID: 37088059
[TBL] [Abstract][Full Text] [Related]
8. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
Shen Q; Xu P; Mei C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
[TBL] [Abstract][Full Text] [Related]
9. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
[TBL] [Abstract][Full Text] [Related]
10. DNA replication stress-induced phosphorylation of cyclic AMP response element-binding protein mediated by ATM.
Dodson GE; Tibbetts RS
J Biol Chem; 2006 Jan; 281(3):1692-7. PubMed ID: 16293623
[TBL] [Abstract][Full Text] [Related]
11. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
12. Induction of
Small SH; Tang EJ; Ragland RL; Ruzankina Y; Schoppy DW; Mandal RS; Glineburg MR; Ustelenca Z; Powell DJ; Simpkins F; Johnson FB; Brown EJ
Sci Signal; 2021 Dec; 14(714):eaba2611. PubMed ID: 34932373
[TBL] [Abstract][Full Text] [Related]
13. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
[TBL] [Abstract][Full Text] [Related]
14. Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders.
Huang Y; Liu B; Sinha SC; Amin S; Gan L
Mol Neurodegener; 2023 Nov; 18(1):79. PubMed ID: 37941028
[TBL] [Abstract][Full Text] [Related]
15. Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.
Balmus G; Zhu M; Mukherjee S; Lyndaker AM; Hume KR; Lee J; Riccio ML; Reeves AP; Sutter NB; Noden DM; Peters RM; Weiss RS
Hum Mol Genet; 2012 Aug; 21(15):3408-20. PubMed ID: 22575700
[TBL] [Abstract][Full Text] [Related]
16. Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes.
Mavroeidi D; Georganta A; Panagiotou E; Syrigos K; Souliotis VL
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474014
[TBL] [Abstract][Full Text] [Related]
17. Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application.
Pu F; Chen F; Liu J; Zhang Z; Shao Z
Onco Targets Ther; 2021; 14():1501-1516. PubMed ID: 33688199
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway.
Jia Y; Li F; Liu Z; Liu S; Huang M; Gao X; Su X; Wang Z; Wang T
J Virol; 2024 Mar; 98(3):e0181523. PubMed ID: 38421179
[TBL] [Abstract][Full Text] [Related]
19. ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.
Zhou Y; Börcsök J; Adib E; Kamran SC; Neil AJ; Stawiski K; Freeman D; Stormoen DR; Sztupinszki Z; Samant A; Nassar A; Bekele RT; Hanlon T; Valentine H; Epstein I; Sharma B; Felt K; Abbosh P; Wu CL; Efstathiou JA; Miyamoto DT; Anderson W; Szallasi Z; Mouw KW
Sci Adv; 2023 Nov; 9(47):eadg2263. PubMed ID: 37992168
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated MRE11 mutants impact ATM/ATR DNA damage signaling by distinct mechanisms.
Regal JA; Festerling TA; Buis JM; Ferguson DO
Hum Mol Genet; 2013 Dec; 22(25):5146-59. PubMed ID: 23912341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
